Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Using principal components of genetic variation for robust and powerful detection of gene-gene interactions in case-control and case-only studies. 20206333 Bhattacharjee S, Wang Z, Ciampa J, Kraft P, Chanock S, Yu K, Chatterjee N Am. J. Hum. Genet. 2010 PLCO
A genome-wide association study of prognosis in breast cancer. 20332263 Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, Caporaso NE, Chanock SJ, Hoover RN, Thomas G, Hunter DJ, Kraft P Cancer Epidemiol. Biomarkers Prev. 2010 PLCO
Powerful SNP-set analysis for case-control genome-wide association studies. 20560208 Wu MC, Kraft P, Epstein MP, Taylor DM, Chanock SJ, Hunter DJ, Lin X Am. J. Hum. Genet. 2010 PLCO
GPC5 rs2352028 variant and risk of lung cancer in never smokers. 20688270 Landi MT, Chatterjee N, Caporaso NE, Rotunno M, Albanes D, Thun M, Wheeler W, Rosenberger A, Bickeböller H, Risch A, Wang Y, Gaborieau V, Thorgeirsson T, Gudbjartsson D, Sulem P, Spitz MR, Wichmann HE, Rafnar T, Stefansson K, Houlston RS, Brennan P Lancet Oncol. 2010 PLCO
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. 20700436 Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DS, Chen X, Cichon S, Giegling I, Han S, Han Y, Keskitalo-Vuokko K, Kong X, Landi MT, Ma JZ, Short SE, Stephens SH, Stevens VL, Sun L, Wang Y, Wenzlaff AS, Aggen SH, Breslau N, Broderick P, Chatter… PLoS Genet. 2010 PLCO
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438 Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Ta… Nat. Genet. 2010 PLCO
Body-mass index and mortality among 1.46 million white adults. 21121834 Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA… N. Engl. J. Med. 2010 PLCO
Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. 21474949 Ferrucci LM, Cross AJ, Gunter MJ, Ahn J, Mayne ST, Ma X, Chanock SJ, Yeager M, Graubard BI, Berndt SI, Huang WY, Hayes RB, Sinha R J Nutrigenet Nutrigenomics 2010 PLCO
Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. 20534171 Nisa H, Kono S, Yin G, Toyomura K, Nagano J, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R BMC Cancer 2010 PLCO
Energy intake and risk of postmenopausal breast cancer: an expanded analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. 19843674 Sue LY, Schairer C, Ma X, Williams C, Chang SC, Miller AB, McCarty CA, Willcox BJ, Ziegler RG Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. 19292893 Lacey JV, Kreimer AR, Buys SS, Marcus PM, Chang SC, Leitzmann MF, Hoover RN, Prorok PC, Berg CD, Hartge P, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Project Team BMC Cancer 2009 PLCO
A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype. 19261719 Kuznetsov IB, McDuffie M, Moslehi R Bioinformatics 2009 PLCO
Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. 19255064 Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N, Freedman ND, Abnet CC, Huang WY, Kibel AS, Crawford ED, Weinstein SJ, Chanock SJ, Schatzkin A, Hayes RB, Prostate, Lung, Colorectal and Ovarian Trial Project Team Carcinogenesis 2009 PLCO
Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. 19568244 Ahn J, Moore SC, Albanes D, Huang WY, Leitzmann MF, Hayes RB, Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Project Team Br. J. Cancer 2009 PLCO
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. 19330027 Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Stratton MR, Rahman N, Jacobs K, Prentice R, Anderson GL, Rajkovic… Nat. Genet. 2009 PLCO
Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. 19223546 Koutros S, Berndt SI, Sinha R, Ma X, Chatterjee N, Alavanja MC, Zheng T, Huang WY, Hayes RB, Cross AJ Cancer Res. 2009 PLCO
Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 19513076 Ferrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, Ma X, Mayne ST, Sinha R Br. J. Cancer 2009 PLCO
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. 19433838 Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE Ann Fam Med 2009 PLCO
The yield of surveillance colonoscopy by adenoma history and time to examination. 18829395 Pinsky PF, Schoen RE, Weissfeld JL, Church T, Yokochi LA, Doria-Rose VP, Prorok P Clin. Gastroenterol. Hepatol. 2009 PLCO
Genome-wide and candidate gene association study of cigarette smoking behaviors. 19247474 Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, Yeager M, Chen C, Jacobs K, Wheeler W, Landi MT, Ziegler RG, Hunter DJ, Chanock S, Hankinson S, Kraft P, Bergen AW PLoS ONE 2009 PLCO